Results 241 to 250 of about 9,202,004 (415)
Clinical &Experimental Ophthalmology, Volume 50, Issue 9, Page 1013-1024, December 2022., 2022 Abstract Background To evaluate the long‐term efficacy and safety of continued repeated low‐level red‐light (RLRL) therapy on myopia control over 2 years, and the potential rebound effect after treatment cessation. Methods The Chinese myopic children who originally completed the one‐year randomised controlled trial were enrolled.
Ruilin Xiong +13 more
wiley +1 more source
UVB induced reactivation leads to HSV1 in the corneas of virtually all latently infected mice and requires STING to develop corneal disease. [PDF]
Sci RepYin XT +6 more
europepmc +1 more source
Gene editing for corneal disease management. [PDF]
World J Transl Med, 2016 Raikwar SP +3 more
europepmc +1 more source
Effect of tear supplements on signs, symptoms and inflammatory markers in dry eye [PDF]
, 2018 Hagan, Suzanne +5 more
core +2 more sources
Evidence of Oxidative Stress in Human Corneal Diseases
, 2002 Rajeev Buddi +5 more
openalex +1 more source
Recent Developments in the Optical Control of Adrenergic Signaling
Medicinal Research Reviews, EarlyView.ABSTRACT Adrenoceptors (ARs) play a vital role in various physiological processes and are key therapeutic targets. The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution. In this review, we summarize the latest advancements in the
Shuang Shi +4 more
wiley +1 more source
Application of artificial intelligence in myopia prevention and control
Pediatric Investigation, EarlyView.Current applications of artificial intelligence (AI) in the field of myopia prevention and control were comprehensively reviewed. Challenges, current development status, and future directions of AI have also been discussed, holding great significance for the further application of AI in myopia management.
Nan Liu, Li Li, Jifeng Yu
wiley +1 more source